Looking Ahead in MedTech Policy: Part 1
Feb 22, 2022•35 min•Ep. 12
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Market Pathways editors Steve Levin and David Filmore discuss important medtech regulatory and policy developments they are looking for in 2022. In this episode, they delve into the US picture, including what to expect from Congress, FDA, and CMS. Check out the second part of the conversation, where they discuss the environments in Europe and Asia, in the next episode.
Read more about the topics discussed in these Market Pathways articles:
Pathways’ Picks for 2022: 7 Medtech Policy Issues to Watch
https://bit.ly/3JNdRUS
Q&A: AdvaMed’s Scott Whitaker on Partnering, Advocacy, and the Medtech Policy Year Ahead
https://bit.ly/3LSDx3U
Device User Fee Talks Stalled as a Deadline Approaches
https://bit.ly/3p86G1A
For the best experience, listen in Metacast app for iOS or Android